{"id":23131,"date":"2021-03-30T20:37:00","date_gmt":"2021-03-31T00:37:00","guid":{"rendered":"https:\/\/joinastudy.ca\/?p=23131"},"modified":"2025-11-18T09:22:02","modified_gmt":"2025-11-18T14:22:02","slug":"amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk","status":"publish","type":"post","link":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/","title":{"rendered":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk"},"content":{"rendered":"\r\n<p>A round of applause for our research site physicians <a href=\"https:\/\/joinastudy.ca\/?post_type=study_location&#038;p=16119\">Dr Sam Henein<\/a> and <a href=\"https:\/\/joinastudy.ca\/study-locations\/bluewater-clinical-research-group\/\">Dr Michael O&rsquo;Mahony<\/a> for their participation in the Amarin REDUCE-IT hypertriglyceridemia study! After more than a decade of development and testing,<a href=\"https:\/\/www.vascepa.com\/\"> VAZKEPA<\/a> becomes the first and only <a href=\"https:\/\/ec.europa.eu\/\">European Commission<\/a>-approved treatment to reduce cardiovascular risk in high-risk, statin-treated adult patients who have elevated triglycerides and other risk characteristics as studied in <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01492361\">REDUCE-IT<\/a>. Keep up the amazing work guys <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/t79\/1\/16\/1f44a.png\" alt=\"\ud83d\udc4a\" width=\"16\" height=\"16\" \/><\/p>\r\n\r\n\r\n\r\n<p><a href=\"https:\/\/investor.amarincorp.com\/news-releases\/news-release-details\/amarin-receives-european-commission-ec-approval-vazkepa-reduce\">https:\/\/investor.amarincorp.com\/news-releases\/news-release-details\/amarin-receives-european-commission-ec-approval-vazkepa-reduce<\/a><\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>A round of applause for our research site physicians Dr Sam Henein and Dr Michael O&rsquo;Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study!<\/p>\n","protected":false},"author":45,"featured_media":17783,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[609,487,550],"tags":[],"class_list":["post-23131","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-heart-health","category-drug-development","category-study-results","category-609","category-487","category-550","description-off"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk<\/title>\n<meta name=\"description\" content=\"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk\" \/>\n<meta property=\"og:description\" content=\"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk\" \/>\n<meta property=\"og:url\" content=\"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/\" \/>\n<meta property=\"og:site_name\" content=\"JoinAStudy.ca\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/joinastudy.ca\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-31T00:37:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-18T14:22:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/joinastudy.ca\/wp-content\/uploads\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"599\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"JoinAStudy Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:site\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"JoinAStudy Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/\"},\"author\":{\"name\":\"JoinAStudy Team\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/5375736fe4f334ff3a12a7d874fc7a27\"},\"headline\":\"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk\",\"datePublished\":\"2021-03-31T00:37:00+00:00\",\"dateModified\":\"2025-11-18T14:22:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/\"},\"wordCount\":87,\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg\",\"articleSection\":[\"Heart Health\",\"Drug Development\",\"Study Results\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/\",\"name\":\"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg\",\"datePublished\":\"2021-03-31T00:37:00+00:00\",\"dateModified\":\"2025-11-18T14:22:02+00:00\",\"description\":\"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg\",\"width\":599,\"height\":683,\"caption\":\"obesity, diabetes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"name\":\"JoinAStudy.ca\",\"description\":\"JoinAStudy.ca - Help create a healthier future\",\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\",\"name\":\"JoinAStudy.ca\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"width\":118,\"height\":65,\"caption\":\"JoinAStudy.ca\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/joinastudy.ca\",\"https:\\\/\\\/x.com\\\/JoinAStudy_ca\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC_ed0XmzH5ImSNOEJcdXKqg\"],\"publishingPrinciples\":\"https:\\\/\\\/joinastudy.ca\\\/why-join-a-study\\\/\",\"ownershipFundingInfo\":\"https:\\\/\\\/joinastudy.ca\\\/information-disclaimer\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/5375736fe4f334ff3a12a7d874fc7a27\",\"name\":\"JoinAStudy Team\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/author\\\/wasif\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk","description":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/","og_locale":"fr_FR","og_type":"article","og_title":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk","og_description":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk","og_url":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/","og_site_name":"JoinAStudy.ca","article_publisher":"https:\/\/www.facebook.com\/joinastudy.ca","article_published_time":"2021-03-31T00:37:00+00:00","article_modified_time":"2025-11-18T14:22:02+00:00","og_image":[{"width":599,"height":683,"url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg","type":"image\/jpeg"}],"author":"JoinAStudy Team","twitter_card":"summary_large_image","twitter_creator":"@JoinAStudy_ca","twitter_site":"@JoinAStudy_ca","twitter_misc":{"\u00c9crit par":"JoinAStudy Team","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/#article","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/"},"author":{"name":"JoinAStudy Team","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/5375736fe4f334ff3a12a7d874fc7a27"},"headline":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk","datePublished":"2021-03-31T00:37:00+00:00","dateModified":"2025-11-18T14:22:02+00:00","mainEntityOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/"},"wordCount":87,"publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg","articleSection":["Heart Health","Drug Development","Study Results"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/","url":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/","name":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/#primaryimage"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg","datePublished":"2021-03-31T00:37:00+00:00","dateModified":"2025-11-18T14:22:02+00:00","description":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk","breadcrumb":{"@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/#primaryimage","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Diabetes-heart-blood-glucose-1024x683-1-e1579618589513.jpg","width":599,"height":683,"caption":"obesity, diabetes"},{"@type":"BreadcrumbList","@id":"https:\/\/joinastudy.ca\/fr\/amarin-receives-approval-for-vazkepa-to-reduce-cardiovascular-risk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/joinastudy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk"}]},{"@type":"WebSite","@id":"https:\/\/joinastudy.ca\/fr\/#website","url":"https:\/\/joinastudy.ca\/fr\/","name":"JoinAStudy.ca","description":"JoinAStudy.ca - Help create a healthier future","publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/joinastudy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/joinastudy.ca\/fr\/#organization","name":"JoinAStudy.ca","url":"https:\/\/joinastudy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","width":118,"height":65,"caption":"JoinAStudy.ca"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/joinastudy.ca","https:\/\/x.com\/JoinAStudy_ca","https:\/\/www.youtube.com\/channel\/UC_ed0XmzH5ImSNOEJcdXKqg"],"publishingPrinciples":"https:\/\/joinastudy.ca\/why-join-a-study\/","ownershipFundingInfo":"https:\/\/joinastudy.ca\/information-disclaimer\/"},{"@type":"Person","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/5375736fe4f334ff3a12a7d874fc7a27","name":"JoinAStudy Team","url":"https:\/\/joinastudy.ca\/fr\/author\/wasif\/"}]}},"_links":{"self":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/23131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/comments?post=23131"}],"version-history":[{"count":1,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/23131\/revisions"}],"predecessor-version":[{"id":35594,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/23131\/revisions\/35594"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media\/17783"}],"wp:attachment":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media?parent=23131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/categories?post=23131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/tags?post=23131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}